CD8A and cancer: Meanwhile, there is growing evidence revealed in the studies on other cancers, that mDCs induced by TEXs mediate stronger CD8+ CTL responses and exhibit enhanced anti-tumor effects compared to cancer cell lysates, which are currently the most widely used for pulsing DCs (134–136).